Apogee Therapeutics Inc
APGE37.727USD
-0.143-0.38%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
2.21BMarket Cap
LossP/E TTM
Apogee Therapeutics Inc
37.727
-0.143-0.38%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q1
Operating expenses
65.25%63.10M
104.23%75.88M
141.46%58.69M
133.64%44.12M
201.64%38.18M
--37.16M
--24.30M
--18.89M
194.03%12.66M
--4.30M
R&D expenses
61.54%46.39M
108.02%60.23M
167.82%45.71M
138.10%33.21M
239.63%28.72M
--28.95M
--17.07M
--13.95M
99.18%8.46M
--4.25M
Depreciation, depletion, and amortization
613.79%207.00K
--76.00K
--48.00K
--36.00K
--29.00K
----
----
----
----
----
Operating profit
-65.25%-63.10M
-104.23%-75.88M
-141.46%-58.69M
-133.64%-44.12M
-201.64%-38.18M
---37.16M
---24.30M
---18.89M
-194.03%-12.66M
---4.30M
Net non-operating interest income (expenses)
Non-operating interest income
28.80%7.84M
60.17%8.68M
179.02%9.67M
--10.31M
4476.69%6.09M
--5.42M
--3.46M
--0.00
--133.00K
--0.00
Income before tax
-72.17%-55.26M
-111.75%-67.20M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Income tax
--83.00K
--18.00K
----
----
----
----
----
----
----
----
Income after tax
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Net income from continuous operations
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Net income attributable to controlling interests
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Net income attributable to common shareholders
-72.43%-55.34M
-111.81%-67.22M
-135.21%-49.02M
-79.06%-33.82M
-156.24%-32.09M
---31.73M
---20.84M
---18.89M
-190.94%-12.53M
---4.30M
Basic earnings per share
-67.01%-0.95
-82.41%-1.17
-98.86%-0.86
-50.86%-0.60
-116.45%-0.57
---0.64
---0.43
---0.40
-190.95%-0.26
---0.09
Diluted earnings per share
-67.01%-0.95
-82.41%-1.17
-98.86%-0.86
-50.86%-0.60
-116.45%-0.57
---0.64
---0.43
---0.40
-190.95%-0.26
---0.09
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
